A Clinical Study To evaluate The Effect Of Gandirikadi Taila In the Treatment of Dadru With special Reference To Tinea Infection

A Randomized Controlled Clinical Study TO Evaluate The Effectiveness of Gandirikadi Taila In The Management Of Dadru Kushta With Special Reference To Tinea Infection - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/109812

Enrollment

Registered

2026-04-30

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B359- Dermatophytosis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients presenting with sign and symptoms of dadru kushta like kandu, Vaivarnya,rookshta,Mandala. 2.patients presenting with Jirna Avastha of Dadru Kushta i.e Having lesion with itching ,discoloration, scaling and history of persistence or recurrence for more than 3 months,will be included in the study. 3.Understanding and being willing to sign the informed consent form

Exclusion criteria

Exclusion criteria: 1.Patients, having skin disease other than Dadru Kustha like Eczema, Psoriasis, Urticaria etc. 2.Immune-compromised patients like AIDS (HIV Positive) HbsAg Positive etc. 3.Person with disorder likes CA. Liver, disorder, renal or cardiac problems, bed ridden, due to chronic illness. 4.patients which uses other ointment or local application. 5.Patient on medication as chemotherapy or radiotherapy. 6.Patient having uncontrolled DM/HTN. 7.Mentally retarded patient and psychologically disturbed.

Design outcomes

Primary

Measure	Time frame
1.To evaluate subject for subjective symptoms like Mandal,Vaivarnya,rookshata, kandu and objective assessment for reducing the area lesions in group Of gandirikadi taila. 2.To evaluate the subject for subjective symptoms symptoms like vaivarnya,Mandal,rookshata ,kandu and objective assessment for reducing the area of lesions in group of ketoconazole cream. 3. To compare the subjective symptoms like vaivarnya, Mandal, rookshata and kandu and objective assessment for reducing the area of lesions between two groups.Timepoint: 1 month	—

Measure

Time frame

1.To evaluate subject for subjective symptoms like Mandal,Vaivarnya,rookshata, kandu and objective assessment for reducing the area lesions in group Of gandirikadi taila. 2.To evaluate the subject for subjective symptoms symptoms like vaivarnya,Mandal,rookshata ,kandu and objective assessment for reducing the area of lesions in group of ketoconazole cream. 3. To compare the subjective symptoms like vaivarnya, Mandal, rookshata and kandu and objective assessment for reducing the area of lesions between two groups.Timepoint: 1 month

—

Secondary

Measure	Time frame
To assess the possible mode of action of gandirikadi taila.Timepoint: 1 month	—

Countries

India

Contacts

Public ContactDr Savita C Samleti

R.A.Podar Govt Ayu college,Worli Mumbai-18

savita_g123@yahoo.co.in9820366734

Outcome results